Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

riTUXimab

riTUXimab
Brand names: Rituxan
Form Strength
SOLUTION, INTRAVENOUS 10 mg/mL

VIEW MORE Antineoplastic Agents
CLASS
100000

Additional Information:

Rituximab is non-formulary for inpatient use.  Rituximab-pvvr (Ruxience) is a "biosimilar" of Rituximab and the LH formulary agent of choice inpatient.  Outpatient selection is based on insurance preference/formulary.

For non-oncologic condition, refer to EHR order set IP Non-Onc Rituximab (#2592) for adults or Peds Rituximab Infusion (#1327) for children.
  (Note: Monoclonal antibodies given for a non-oncologic condition do not require a chemotherapy certified nurse).

For oncologic condition, refer to the EHR order set IP Onc Rituximab (#1935) or the appropriate order set that contains rituximab as part of the chemotherapy protocol.
  (NOTE: Monoclonal antibodies given as part of a chemotherapy protocol will be given by a chemotherapy certified RN.)

Administration and Handling of antineoplastic drugs: Policy 906.4802

May be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991

Rituximab may only be ordered via Order Set.  See 900.3233 Medications: Orders


Last updated: Nov. 1, 2021







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.